Atossa Therapeutics Inc
Atossa Therapeutics Inc (ATOS) Option Chain
Read more
Tracking the ATOS option chain helps you see every strike and expiry on Atossa Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ATOS options activity at a glance. Use our scanner to monitor the ATOS option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ATOS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ATOS options are being actively traded, and where they are not.
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 0 | 0 | 0.03 | 0.75 | 0.30 | 1.25 | 1.00 | -42.86 | — | 0.75 | 0.00 | 0.75 | 0 | 1 | 100.00 |
| 98.69 | 7 | 0 | 0.05 | 0.00 | — | 0.05 | 2.00 | +14.29 | — | 0.65 | 0.25 | 0.40 | 0 | 18 | 1.30 |
| 100.00 | 18 | 0 | 0.20 | 0.00 | — | 0.20 | 3.00 | +71.43 | 0.75 | 1.75 | 1.25 | 0.00 | 0 | 0 | 0.00 |
| 100.00 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 4.00 | +128.57 | 1.80 | 2.75 | 2.25 | 0.02 | 0 | 0 | 0.00 |
| 100.00 | 3 | 0 | 0.20 | 0.00 | — | 0.20 | 5.00 | +185.71 | 2.80 | 3.80 | 3.25 | 0.05 | 0 | 0 | 0.00 |
As of Nov 18, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank43.25% Moderate
- Market cap (M$)17
- 52 weeks high-88.22%
- 52 weeks low2.94%
- Analyst recommendationStrong Buy
1.00 - Target price$19.00
985.71% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-10
- P/E—
- Future P/E—
- EPS (ttm)-3.90
- EPS growth next 5 years—
As of Nov 18, 2026